2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine
Modify Date: 2024-01-13 08:06:19
![2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine Structure](https://www.chemsrc.com/caspic/031/1260177-41-0.png)
2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine structure
|
Common Name | 2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine | ||
|---|---|---|---|---|
| CAS Number | 1260177-41-0 | Molecular Weight | 412.78 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H17ClN4O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | (2R,3R,4R,5R)-2-(acetoxymethyl)-5-(2-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate |
|---|
| Description | 2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C16H17ClN4O7 |
|---|---|
| Molecular Weight | 412.78 |
| Exact Mass | 412.07900 |
| PSA | 131.73000 |
| LogP | 0.80360 |
|
~87%
2-Chloro-9-[(2,... CAS#:1260177-41-0 |
| Literature: Gillerman, Irina; Fischer, Bilha Journal of Medicinal Chemistry, 2011 , vol. 54, # 1 p. 107 - 121 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
CAS#:5466-11-5